The American Cancer Society estimates that there will be about 8,300 new anal cancer cases and about 1,280 deaths from anal cancer in the United States in 2019. Because treatment for anal cancer is often very effective, and many patients with this cancer can be cured, early detection is important for survival. The Prevent Anal Cancer study (PAC) is a research project funded by the National Institutes of Health - National Cancer Institute. The study is researching new and unique methods to test for anal cancer in men who have sex with men and transwomen in Milwaukee, Chicago and Houston.

This study is led by Dr. Alan Nyitray at the Medical College of Wisconsin in partnership with community based organizations, local area clinics and other research institutions. We are looking for study participants, who if eligible, will be compensated for their participation in the project. Click on the + buttons below to take the eligibility survey, learn more about the project and study team, and learn more about anal cancer.